Cargando…
Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo
BACKGROUND: Silence of the tumor suppressor miR-34c is implicated in the development of colorectal cancer (CRC). For the past few years, Resveratrol (Res) has been introduced to oncotherapies alone or with traditional chemotherapeutic drugs. However, the study of molecular mechanism involved in the...
Autores principales: | Yang, Shu, Li, Wenshuai, Sun, Haimei, Wu, Bo, Ji, Fengqing, Sun, Tingyi, Chang, Huanhuan, Shen, Ping, Wang, Yaxi, Zhou, Deshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682213/ https://www.ncbi.nlm.nih.gov/pubmed/26674205 http://dx.doi.org/10.1186/s12885-015-1958-6 |
Ejemplares similares
-
Interrupted E2F1-miR-34c-SCF negative feedback loop by hyper-methylation promotes colorectal cancer cell proliferation
por: Yang, Shu, et al.
Publicado: (2016) -
Persistent distention of colon damages interstitial cells of Cajal through Ca(2+)‐ERK‐AP‐1‐miR‐34c‐SCF deregulation
por: Yang, Shu, et al.
Publicado: (2017) -
KITLG is a novel target of miR-34c that is associated with the inhibition of growth and invasion in colorectal cancer cells
por: Yang, Shu, et al.
Publicado: (2014) -
SCF/C-Kit/JNK/AP-1 Signaling Pathway Promotes Claudin-3 Expression in Colonic Epithelium and Colorectal Carcinoma
por: Wang, Yaxi, et al.
Publicado: (2017) -
SCF/c-KIT Signaling Increased Mucin2 Production by Maintaining Atoh1 Expression in Mucinous Colorectal Adenocarcinoma
por: Shen, Ping, et al.
Publicado: (2018)